Table 4.
Parameters of interest in nephrosclerosis patients experiencing or not cardiovascular events. Median (range) or count (percentages) are shown.
| Variable | No CVE | CVE | p Value |
|---|---|---|---|
| Age (years) | 66 (59–71) | 67 (64–72.5) | 0.014 |
| Sex (male) | 300 (66.4) | 34 (82.9) | 0.019 |
| Ethnicity | |||
| Caucasian | 441 (97.6) | 41 (100) | 0.381 |
| Others | 11 (2.4) | 0 | |
| Weight | 79.8 (69.7–88) | 81.5 (70.9–91.5) | 0.568 |
| BMI (kg/m²) | 29.8 (26.5–33.4) | 29.7 (26.1–33) | 0.923 |
| Hypertension | 435 (96.2) | 39 (95.1) | 0.480 |
| DM | 100 (22.1) | 14 (34.1) | 0.064 |
| Hyperlipidemia | * 284 (67.8) | 30 (73.2) | 0.302 |
| Smoking | |||
| Non-smoker | 190 (42.0) | 13 (31.7) | 0.224 |
| Current-smoker | 77 (17.0) | 11 (26.8) | |
| Former-smoker | 185 (49.9) | 17 (41.5) | |
| Pulse pressure (mmHg) | 62 (51–75.4) | 67 (57.3–78.3) | 0.096 |
| Systolic lood pressure (mmHg) | 144 (132–160) | 145 (134–162) | 0.642 |
| Dyastolic blood pressure (mmHg) | 81 (74–89) | 77.5 (70.8–88.8) | 0.245 |
| Chronic kidney disease stage | |||
| Stage 3 | 282 (62.4) | 25 (61.0) | 0.933 |
| Stage 4–5 | 113 (25.0) | 10 (24.4) | |
| Dialysis | 57 12.6) | 6 (14.6) | |
| Total cholesterol (mg/dL) | 181 (154.7–209) | 165 (139.5–212) | 0.065 |
| Creatinine (mg/dL) | 1.7 (1.4–2.4) | 1.7 (1.3–2.3) | 0.689 |
| Albumin/Cr (mg/g) | 68.9 (9.9–294.3) | 173.6 (25.5–470.6) | 0.171 |
| eGFR (mL/min/1.73 m²) | 38.2 (26.6–47.7) | 37.4 (25–47) | 0.705 |
| Glucose (mg/dL) | 100.5 (90–114) | 102 (96.5–123.5) | 0.134 |
| Calcium (mg/dL) | 9.4 (9.1–9.7) | 9.5 (9.1–9.7) | 0.947 |
| Sodium (mEq/L) | 141 (139–142) | 141 (139–142) | 0.951 |
| Potassium (mEq/L) | 4.7 (4.4–5.1) | 4.8 (4.4–5) | 0.946 |
* Dyslipemia data was missing in 33 individuals.